Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dengue virus envelope protein (DEN-80E)
- Molecular classification
- Viral protein, Glycoprotein
01
Overview
The Dengue virus envelope protein (DEN-80E) is a recombinant, truncated form of the dengue virus envelope (E) protein, comprising approximately 80% of the full-length E protein. It mediates viral attachment and fusion during cell entry and is a major target for neutralizing antibodies. DEN-80E is used as an antigen in experimental tetravalent subunit vaccines.
02
Biological functions
Viral entryReceptor bindingMembrane fusionAntigen presentationImmune response
03
Disease associations
Infection
Beyond the preview
Go deeper on Dengue virus envelope protein (DEN-80E).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dengue virus envelope protein (DEN-80E).